PNC Financial Services Group
MLYS icon

PNC Financial Services Group’s Mineralys Therapeutics MLYS Stock Holding History

PNC Financial Services Group’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$57.2K Buy
2,278
+44
+2% +$1.2K ﹤0.01% 3307
2026
Q2 		$60.3K Hold
2,234
– – ﹤0.01% 3240
2026
Q1 		$60.5K Hold
2,234
– – ﹤0.01% 3114
2025
Q4 		$81.1K Hold
2,234
– – ﹤0.01% 2937
2025
Q3 		$84.7K Hold
2,234
– – ﹤0.01% 2914
2025
Q2 		$30.2K Buy
2,234
+28
+1% +$406 ﹤0.01% 3369
2025
Q1 		$35K Buy
2,206
+21
+1% +$242 ﹤0.01% 3284
2024
Q4 		$26.9K Sell
2,185
-26
-1% -$340 ﹤0.01% 3395
2024
Q3 		$26.8K Hold
2,211
– – ﹤0.01% 3377
2024
Q2 		$25.9K Hold
2,211
– – ﹤0.01% 3353
2024
Q1 		$28.5K Sell
2,211
-1,911
-46% -$23.6K ﹤0.01% 3260
2023
Q4 		$35.4K Buy
4,122
+4,099
+17,822% +$32.2K ﹤0.01% 3136
2023
Q3 		$219 Buy
+23
New +$300 ﹤0.01% 4529

Other funds holding MLYS

Catalys Pacific
Catalys Pacific Tokyo, Japan $210M AUM 33.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Laurion Capital Management
Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Andera Partners
Andera Partners Paris $176M AUM 1.8% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

PNC Financial Services Group's MLYS Position: Q3 2026 in Review

PNC Financial Services Group increased its Mineralys Therapeutics (MLYS) stake by 2% in Q3 2026, buying an estimated $1.2K and bringing the position to 2,278 shares worth $57.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3307.

PNC Financial Services Group first reported a position in MLYS in Q3 2023 and has held it in 13 quarters since. The position peaked at $84.7K in Q3 2025. 130 funds tracked by Wall St. Rank hold MLYS as of Q3 2026.

  • PNC Financial Services Group held 2,278 shares of Mineralys Therapeutics worth $57.2K as of Q3 2026.
  • PNC Financial Services Group bought 44 Mineralys Therapeutics shares in Q3 2026, an estimated $1.2K.
  • Mineralys Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #3307 holding.
  • PNC Financial Services Group first reported a position in Mineralys Therapeutics in Q3 2023 and has held it in 13 quarters since.
  • PNC Financial Services Group's Mineralys Therapeutics position peaked at $84.7K in Q3 2025.
  • 130 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.